bleximenib (JNJ-6617) - J&J
icovamenib (BMF-219) - Biomea Fusion
ziftomenib (KO-539) - Kura Oncology, Kyowa Kirin
emilumenib succinate (DS-1594) - Daiichi Sankyo
Revuforj (revumenib) - Syndax Pharma
enzomenib (DSP-5336) - Sumitomo Pharma, Kyoto University
http://www.ncbi.nlm.nih.gov/pubmed/40441466
 
Abdulrahman F Al-Mashdali; Anas Kalfah; Sara Al Dali; Shehab F Mohamed
 
May 30, 2025
 
Prev Next